Sphera Funds Management’s Werewolf Therapeutics HOWL Stock Holding History

Sphera Funds Management’s Portfolio HOWL Stock Details HOWL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Hold	626,810	–	–	0.03%	104
2026 Q1	$522K	Hold	626,810	–	–	0.08%	92
2025 Q4	$397K	Hold	626,810	–	–	0.08%	92
2025 Q3	$1.23M	Hold	626,810	–	–	0.26%	92
2025 Q2	$683K	Hold	626,810	–	–	0.16%	95
2025 Q1	$609K	Hold	626,810	–	–	0.14%	100
2024 Q4	$928K	Hold	626,810	–	–	0.17%	94
2024 Q3	$1.33M	Hold	626,810	–	–	0.21%	95
2024 Q2	$1.53M	Hold	626,810	–	–	0.21%	94
2024 Q1	$4.06M	Hold	626,810	–	–	0.57%	56
2023 Q4	$2.42M	Hold	626,810	–	–	0.39%	70
2023 Q3	$1.34M	Hold	626,810	–	–	0.24%	70
2023 Q2	$1.91M	Hold	626,810	–	–	0.3%	72
2023 Q1	$1.63M	Hold	626,810	–	–	0.27%	63
2022 Q4	$1.28M	Hold	626,810	–	–	0.28%	48
2022 Q3	$2.83M	Buy	626,810 +29,807	+5%	+$162K	0.39%	52
2022 Q2	$2.44M	Buy	597,003 +12,800	+2%	+$58.4K	0.26%	40
2022 Q1	$2.57M	Sell	584,203 -64,188	-10%	-$450K	0.36%	53
2021 Q4	$7.72M	Sell	648,391 -40,084	-6%	-$605K	0.85%	41
2021 Q3	$11.8M	Sell	688,475 -17,819	-3%	-$304K	0.99%	24
2021 Q2	$12M	Buy	+706,294	New	+$9.68M	0.82%	36

Other funds holding HOWL

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DC Funds Mclean, Virginia $1.25M AUM 26.51% 1-Year Est. Return

Verdad Advisers Boston, Massachusetts $104M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Sphera Funds Management's HOWL Position: Q2 2026 in Review

Sphera Funds Management held its Werewolf Therapeutics (HOWL) position steady in Q2 2026 at 626,810 shares worth $226K. The position accounts for 0.03% of the portfolio, ranked #104.

Sphera Funds Management first reported a position in HOWL in Q2 2021 and has held it in 21 quarters since. The position peaked at $12M in Q2 2021. 45 funds tracked by Wall St. Rank hold HOWL as of Q2 2026.

Sphera Funds Management held 626,810 shares of Werewolf Therapeutics worth $226K as of Q2 2026.
Sphera Funds Management left its Werewolf Therapeutics share count unchanged in Q2 2026.
Werewolf Therapeutics made up 0.03% of Sphera Funds Management's portfolio in Q2 2026, its #104 holding.
Sphera Funds Management first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 21 quarters since.
Sphera Funds Management's Werewolf Therapeutics position peaked at $12M in Q2 2021.
45 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.